Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

NCT01338818 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit/Hyperactivity Disorder

Interventions

DRUG: Ritalin LA (methylphenidate hydrochloride extended release)

Sponsor

Novartis Pharmaceuticals